- Wealth Awesome
- Posts
- 📈 🇨🇦 TSX Movers: Top Gainers & Losers (June 27th)
📈 🇨🇦 TSX Movers: Top Gainers & Losers (June 27th)
Week Ending June 27th 2025
Qayyum Rajan
June 28, 2025
In partnership with
🇨🇦 The Canadian TSX reached an all-time high last week, now up nearly 8% year-to-date and 23% since April, buoyed by falling oil prices, easing geopolitical tensions, and expectations of further rate cuts by the Bank of Canada, which has already lowered its policy rate from 5% to 2.75%.
Canadian inflation has declined to under 2.5%, and retail sales have softened, supporting the case for more cuts.
Despite potential volatility from trade negotiations and economic softness, the market outlook remains constructive with equities continuing to benefit from improving sentiment and lower bond yields.
You found global talent. Deel’s here to help you onboard them
Deel’s simplified a whole planet’s worth of information. It’s time you got your hands on our international compliance handbook where you’ll learn about:
Attracting global talent
Labor laws to consider when hiring
Processing international payroll on time
Staying compliant with employment & tax laws abroad
With 150+ countries right at your fingertips, growing your team with Deel is easier than ever.
Here's a summary of the top-performing and underperforming stocks on the Toronto Stock Exchange (TSX) over the past week:
📈 Top Gainers
Symbol | Name | Last Price (CAD) | % Change |
|---|---|---|---|
Eupraxia Pharmaceuticals Inc | 7.35 | 🟩🟩🟩 +15.20% | |
Almonty Industries Inc | 4.27 | 🟩🟩 +10.34% | |
Cae Inc | 38.47 | 🟩🟩 +5.28% | |
EQB Inc | 103.70 | 🟩🟩 +5.02% | |
Kits Eyecare Ltd | 14.54 | 🟩 +4.30% |
📉 Top Decliners
Symbol | Name | Last Price (CAD) | % Change |
|---|---|---|---|
Tecsys Inc J | 36.40 | 🟥🟥🟥 -9.97% | |
Platinum Group Metals Ltd | 2.02 | 🟥🟥 -8.18% | |
Lundin Gold Inc | 67.51 | 🟥🟥 -7.92% | |
Perpetua Resources Corp | 16.25 | 🟥🟥 -7.57% | |
G Mining Ventures Corp | 17.11 | 🟥🟥 -7.51% |
Eupraxia Pharmaceuticals (EPRX-T), a clinical-stage biotech firm focused on drug delivery for unmet medical needs, recently reported positive Phase 1b/2a trial results for its EoE treatment candidate, EP-104GI. Following the announcement, director Joseph Freedman purchased 33,400 shares between June 16–18 at an average of $5.49, signaling insider confidence. The stock has since surged, closing at $7.35, up 15.2%.
Oil in New Zealand? You heard right.
Monumental Energy (TSXV: MNRG | OTCQB: MNMRF) is reactivating proven wells with near-term cash flow potential—and FX tailwinds to boost profits.
With insider buying and a summer catalyst timeline, this small-cap could punch above its weight.
👉 Discover why now could be the moment to watch Monumental.
Tecsys Inc. (TSE:TCS) reported strong fiscal 2025 results, with SaaS revenue rising 29% and adjusted EBITDA up 55%. The company launched its AI-driven TecsysIQ platform and plans to increase R&D and marketing investments in 2026 to support further growth. Analysts remain optimistic, with a "Buy" rating and a C$45 price target, though high valuations and mixed future guidance have tempered enthusiasm slightly.
Reply